Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

INO RSS Feed
Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Tonyeight, KarinCA, biovalidator, KingDMC
Search This Board:
Last Post: 11/20/2014 9:47:53 PM - Followers: 399 - Board type: Free - Posts Today: 0

Logo: Inovio

www.inovio.com/

http://finance.yahoo.com/q/ks?s=INO

http://finance.aol.com/company/inovio-biomedical-corporation/ino/ase/institutional-ownership

F
ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE- http://www.youtube.com/watch?v=95yO6hFpbUM


Float: 97.65 M

Shares Outstanding: 127.26 M


Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
 
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis
http://finance.yahoo.com/news/inovio-pharmaceuticals-acquires-early-stage-080000624.html?.tsrc=applewf

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
http://finance.yahoo.com/news/inovio-pharmaceuticals-announces-1-4-080000629.html
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.


Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



 
 



 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
INO
Current Price
Volume:
Bid Ask Day's Range
Wiki
INO News: Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bac... 10/21/2014 06:00:00 AM
INO News: Inovio Pharmaceuticals Appoints Vice President of Commercial Development 09/30/2014 07:00:00 AM
INO News: Inovio Pharmaceuticals Ebola Vaccine Moving into Human Trial with GeneOne Life Science 09/24/2014 06:00:00 AM
INO News: Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 09/22/2014 08:00:00 AM
INO News: Inovio to Present at Upcoming Investor Conferences 09/18/2014 06:00:00 AM
PostSubject
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#659   Did anyone notice more sells than buys today Paulness 01/31/12 11:03:47 AM
#658   Nice Volume so far today... mnelsonm 01/31/12 10:18:03 AM
#657   yes...saw that...could be huge Med.rare 01/31/12 09:37:18 AM
#656   4:10AM Inovio Pharma moves closer to 'universal' influenza surf1944 01/31/12 09:19:52 AM
#655   another nice day for INO... Med.rare 01/27/12 05:08:09 PM
#654   Inovio Pharmaceuticals and Keryx Biopharmaceuticals Benefit From Strengthening surf1944 01/25/12 10:51:39 AM
#653   Pick a GREAT company then All it takes makingbiigdough 01/24/12 10:20:57 AM
#652   Round Two, Amigo Capt_Smith77 01/24/12 09:46:35 AM
#651   Between INO and ACTC....it was a good Med.rare 01/24/12 09:39:56 AM
#650   Accumulation, WOW, great day!!! Paulness 01/23/12 11:41:46 PM
#649   break out1 Med.rare 01/23/12 02:57:06 PM
#648   this could be our breakout alert. lets Med.rare 01/23/12 01:01:58 PM
#647   why is this moving? is this a bird MakinBank 01/23/12 11:08:17 AM
#646   Thank you for INO summary. Its electroporation delivery wmkjoh 01/22/12 02:41:54 PM
#645   enough consolidating between >40 and .43....need to get Med.rare 01/20/12 10:18:57 AM
#644   Lots of people buying today, but Market Makers Paulness 01/18/12 01:45:35 PM
#643   what's the deal with the high volume today. DrBob99 01/17/12 05:12:57 PM
#642   welcome...good to see a familiar name.... Med.rare 01/17/12 02:53:23 PM
#641   Bought some today future looks bright for INO. Paulness 01/17/12 11:40:01 AM
#640   nice find...thanks for posting Med.rare 01/16/12 08:29:24 AM
#639   Universal Flu Vaccine Could Be Available by 2013 nanopatent 01/15/12 06:52:27 PM
#638   INO RESEARCH / DD SUMMARY!!! $tockfather 01/12/12 09:38:13 PM
#637   PATIENCE pays off BIGTIME here imo! Good Luck makingbiigdough 01/11/12 10:44:28 AM
#636   Insider Buying 1/5/2012, Me too...GL FinaleSchnaps 01/06/12 09:48:54 AM
#635   almost half the daily volume in the first Med.rare 01/04/12 09:55:44 AM
#634   Resistance @ .435 and .44..if it busts thru freshcoat 12/29/11 06:35:13 PM
#633   Same, +1 bigboyjones 12/29/11 10:25:53 AM
#632   Following the chatter. INO Board & mods marked. PoemStone 12/28/11 12:45:01 PM
#631   AGREED!! Have been adding all along. GREAT BUYS makingbiigdough 12/19/11 10:11:53 AM
#630   I agree. It's unfortunate some can't see ThinkitThru 12/17/11 01:39:30 AM
#629   Nano, I wrote to Investor Relations complaining about the Ripantuck 12/07/11 04:02:22 PM
#628   http://www.secform4.com/insider-trading/1055726.htm surf1944 12/04/11 07:33:47 PM
#627   Funds buying in. nanopatent 12/04/11 06:57:01 PM
#626   What kind of radical change? Sorry,but I Ripantuck 12/04/11 06:00:56 PM
#625   Could portend a radical change of some considerable import! nanopatent 12/02/11 08:53:06 PM
#624   What happened to cause this SP decline? Ripantuck 12/02/11 06:29:48 PM
#623   I have no clue at all. nanopatent 12/01/11 05:03:54 PM
#622   Inovio Pharma announces $3.5 mln underwritten financing (INO) mlkrborn 12/01/11 03:46:34 PM
#621   yes but it didn't happen ~ Blue ~ 12/01/11 02:26:25 PM
#620   are you sure? [SMART MONEY] 12/01/11 02:25:37 PM
#619   I think .48 will hit by eod 20% [SMART MONEY] 12/01/11 02:24:12 PM
#618   nothing concrete yet.. it will take at list ~ Blue ~ 12/01/11 01:56:14 PM
#617   Not sure, just IMO, I seen a bottom jedijazz 12/01/11 01:52:03 PM
#616   expecting another big dump here.. ~ Blue ~ 12/01/11 01:32:15 PM
#615   INO is a good intraday trade today I jedijazz 12/01/11 01:09:35 PM
#614   WHY DO YOU THINK (INO .40) flopped on [SMART MONEY] 12/01/11 10:34:47 AM
#613   Placing INO back on the watch list this morning: surf1944 12/01/11 09:47:27 AM
#612   (WO2011137221) ORAL MUCOSAL ELECTROPORATION DEVICE AND USE THEREOF nanopatent 11/17/11 04:49:20 PM
#611   Inovio Pharma announced earlier Synthetic Avian flu vaccine mlkrborn 11/17/11 08:54:20 AM
#610   Q looks VERY good and above what i makingbiigdough 11/07/11 07:54:53 AM
PostSubject